Jundishapur Journal of Microbiology

Published by: Kowsar

Pectate Lyase Promoting Streptolysin O Expression in Escherichia coli and Strengthening Its Activity

Zhao Qingxin 1 , * , He Jing 2 , Ye Kaixia 1 , 3 , Wang Jian 1 , Kang Yijun 1 , Shen Min 1 and Wang Huanli 1
Authors Information
1 Jiangshu Key Laboratory for Bioresources of Saline Solis, Yancheng Teachers University, Yancheng, People’s Republic of China
2 Neurology Department, Qianfoshan Hospital of Shandong Province, People’s Republic of China
3 College of Food Science and Light Industry, Nanjing Tech University, Nanjing, People’s Republic of China
Article information
  • Jundishapur Journal of Microbiology: September 2017, 10 (9); e14337
  • Published Online: September 8, 2017
  • Article Type: Research Article
  • Received: February 27, 2017
  • Revised: May 31, 2017
  • Accepted: June 24, 2017
  • DOI: 10.5812/jjm.14337

To Cite: Qingxin Z, Jing H, Kaixia Y, Jian W, Yijun K, et al. Pectate Lyase Promoting Streptolysin O Expression in Escherichia coli and Strengthening Its Activity, Jundishapur J Microbiol. 2017 ; 10(9):e14337. doi: 10.5812/jjm.14337.

Copyright © 2017, Jundishapur Journal of Microbiology. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
  • 1. Abe Y, Alouf JE, Kurihara T, Kawashima H. Species-dependent response to streptococcal lymphocyte mitogens in rabbits, guinea pigs, and mice. Infect Immun. 1980; 29(2): 814-8[PubMed]
  • 2. Alouf JE. Streptococcal toxins (streptolysin O, streptolysin S, erythrogenic toxin). Pharmacol Ther. 1980; 11(3): 661-717[PubMed]
  • 3. Alouf JE. Cholesterol-binding cytolytic protein toxins. Int J Med Microbiol. 2000; 290(4-5): 351-6[DOI][PubMed]
  • 4. Bhakdi S, Tranum-Jensen J, Sziegoleit A. Mechanism of membrane damage by streptolysin-O. Infect Immun. 1985; 47(1): 52-60[PubMed]
  • 5. Billington SJ, Jost BH, Songer JG. Thiol-activated cytolysins: structure, function and role in pathogenesis. FEMS Microbiol Lett. 2000; 182(2): 197-205[DOI][PubMed]
  • 6. Feil SC, Ascher DB, Kuiper MJ, Tweten RK, Parker MW. Structural studies of Streptococcus pyogenes streptolysin O provide insights into the early steps of membrane penetration. J Mol Biol. 2014; 426(4): 785-92[DOI][PubMed]
  • 7. Gupta RK. Antibody response to streptolysin O in mammals. J Infect Dis. 1980; 142(4): 624[PubMed]
  • 8. O'Seaghdha M, Wessels MR. Streptolysin O and its co-toxin NAD-glycohydrolase protect group A Streptococcus from Xenophagic killing. PLoS Pathog. 2013; 9(6)[DOI][PubMed]
  • 9. Palmer M. The family of thiol-activated, cholesterol-binding cytolysins. Toxicon. 2001; 39(11): 1681-9[PubMed]
  • 10. Walker MJ, Barnett TC, McArthur JD, Cole JN, Gillen CM, Henningham A, et al. Disease manifestations and pathogenic mechanisms of Group A Streptococcus. Clin Microbiol Rev. 2014; 27(2): 264-301[DOI][PubMed]
  • 11. Walev I, Bhakdi SC, Hofmann F, Djonder N, Valeva A, Aktories K, et al. Delivery of proteins into living cells by reversible membrane permeabilization with streptolysin-O. Proc Natl Acad Sci U S A. 2001; 98(6): 3185-90[DOI][PubMed]
  • 12. Naruse K, Quan YS, Kim BC, Choi SM, Park CS, Jin DI. Streptolysin-o treatment of fetal fibroblasts improves cell fusion and in vitro development of porcine nuclear transfer embryos. J Reprod Dev. 2009; 55(3): 236-9[PubMed]
  • 13. Horohov DW, Loynachan AT, Page AE, Hughes K, Timoney JF, Fettinger M, et al. The use of streptolysin O (SLO) as an adjunct therapy for Rhodococcus equi pneumonia in foals. Vet Microbiol. 2011; 154(1-2): 156-62[DOI][PubMed]
  • 14. Gurel V, Lambert K, Page AE, Loynachan AT, Huges K, Timoney JF, et al. Streptolysin-O/antibiotics adjunct therapy modulates site-specific expression of extracellular matrix and inflammatory genes in lungs of Rhodococcus equi infected foals. Vet Res Commun. 2013; 37(2): 145-54[DOI][PubMed]
  • 15. Kimoto H, Fujii Y, Hirano S, Yokota Y, Taketo A. Expression of recombinant Streptolysin O and specific antibody production. J Mol Microbiol Biotechnol. 2005; 10(1): 64-8[DOI][PubMed]
  • 16. Fiorentini GP, Volpe G. [Determination of anti-streptolysin O antibodies, using micromethods]. Quad Sclavo Diagn. 1980; 16(1): 25-9[PubMed]
  • 17. Velazquez B, Massaldi H, Battistoni J, Chabalgoity JA. Construction and expression of recombinant streptolysin-o and preevaluation of its use in immunoassays. Clin Diagn Lab Immunol. 2005; 12(5): 683-4[DOI][PubMed]
  • 18. Camprubi S, Bruguera M, Canalias F. Purification of recombinant histidine-tag streptolysin O using immobilized metal affinity expanded bed adsorption (IMA-EBA). Int J Biol Macromol. 2006; 38(2): 134-9[DOI][PubMed]
  • 19. Zhao Q, Yuan S, Wang X, Zhang Y, Zhu H, Lu C. Restoration of mature etiolated cucumber hypocotyl cell wall susceptibility to expansin by pretreatment with fungal pectinases and EGTA in vitro. Plant Physiol. 2008; 147(4): 1874-85[DOI][PubMed]
  • 20. Chevallet M, Luche S, Rabilloud T. Silver staining of proteins in polyacrylamide gels. Nat Protoc. 2006; 1(4): 1852-8[DOI][PubMed]
  • 21. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976; 72: 248-54[DOI][PubMed]
  • 22. Herbert D, Todd EW. Purification and properties of a haemolysin produced by group A haemolytic streptococci (streptolysin O). Biochem J. 1941; 35(10-11): 1124-39[PubMed]
  • 23. Pinkney M, Kapur V, Smith J, Weller U, Palmer M, Glanville M, et al. Different forms of streptolysin O produced by Streptococcus pyogenes and by Escherichia coli expressing recombinant toxin: cleavage by streptococcal cysteine protease. Infect Immun. 1995; 63(7): 2776-9[PubMed]
  • 24. Kogo H, Shimizu M, Negishi Y, Uchida E, Takahashi H. Suppression of murine tumour growth through CD8+ cytotoxic T lymphocytes via activated DEC-205+ dendritic cells by sequential administration of alpha-galactosylceramide in vivo. Immunology. 2017; 151(3): 324-39[DOI][PubMed]
  • 25. Wang S. Optimal Sequential Immunization Can Focus Antibody Responses against Diversity Loss and Distraction. PLoS Comput Biol. 2017; 13(1)[DOI][PubMed]
  • 26. Agadjanyan MG, Zagorski K, Petrushina I, Davtyan H, Kazarian K, Antonenko M, et al. Humanized monoclonal antibody armanezumab specific to N-terminus of pathological tau: characterization and therapeutic potency. Mol Neurodegener. 2017; 12(1): 33[DOI][PubMed]
  • 27. Najar TA, Khare S, Pandey R, Gupta SK, Varadarajan R. Mapping Protein Binding Sites and Conformational Epitopes Using Cysteine Labeling and Yeast Surface Display. Structure. 2017; 25(3): 395-406[DOI][PubMed]
  • 28. Cunningham MW. Pathogenesis of group A streptococcal infections. Clin Microbiol Rev. 2000; 13(3): 470-511[DOI][PubMed]
  • 29. Chiarot E, Faralla C, Chiappini N, Tuscano G, Falugi F, Gambellini G, et al. Targeted amino acid substitutions impair streptolysin O toxicity and group A Streptococcus virulence. MBio. 2013; 4(1)-12[DOI][PubMed]
  • 30. Johnson S, Brooks NJ, Smith RA, Lea SM, Bubeck D. Structural basis for recognition of the pore-forming toxin intermedilysin by human complement receptor CD59. Cell Rep. 2013; 3(5): 1369-77[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments